In addition, the deletion of TrkB in neural stem/progenitor cells, or the pharmacological inhibition of ERK signaling also abolished ketamine-induced behavioral responses in depression- and anxiety-like paradigms [23], suggesting that dysfunctional TrkB in the neurogenic niche can be an etiological factor for refractory depression. This evidence concerns the gene NTRK2 and major depressive disorder.